Immunogenicity after second and third mRNA-1273 vaccination doses in patients receiving chemotherapy, immunotherapy, or both for solid tumours

Detalles Bibliográficos
Autores principales: Oosting, Sjoukje F, van der Veldt, Astrid A M, Fehrmann, Rudolf S N, GeurtsvanKessel, Corine H, van Binnendijk, Rob S, Dingemans, Anne-Marie C, Smit, Egbert F, Hiltermann, T Jeroen N, den Hartog, Gerco, Jalving, Mathilda, Westphal, Tatjana T, Bhattacharya, Arkajyoti, de Wilt, Faye, Boerma, Annemarie, van Zijl, Lisanne, Rimmelzwaan, Guus F, Kvistborg, Pia, van Els, Cecile A C M, Rots, Nynke Y, van Baarle, Debbie, Haanen, John B A G, de Vries, Elisabeth G E
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier Ltd. 2022
Materias:
Comment
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236566/
https://www.ncbi.nlm.nih.gov/pubmed/35483383
http://dx.doi.org/10.1016/S1470-2045(22)00203-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9236566/
https://www.ncbi.nlm.nih.gov/pubmed/35483383
http://dx.doi.org/10.1016/S1470-2045(22)00203-0

Ejemplares similares